Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,908
archived clinical trials in
Renal Impairment / Chronic Kidney Disease

Renal Artery Contrast-Free Trial
Comparison of Non-contrast Renal Artery Magnetic Resonance Angiography With Contrast-enhanced CT Angiography
Status: Enrolling
Updated:  8/24/2015
Central Coast Cardiolgy
mi
from
Salinas, CA
Renal Artery Contrast-Free Trial
Comparison of Non-contrast Renal Artery Magnetic Resonance Angiography With Contrast-enhanced CT Angiography
Status: Enrolling
Updated: 8/24/2015
Central Coast Cardiolgy
mi
from
Salinas, CA
Click here to add this to my saved trials
The Effects of Obesity and Protein Intake on the Kidney
The Effects of Obesity and Protein Intake on the Kidney
Status: Enrolling
Updated:  8/26/2015
University Hospital
mi
from
Indianapolis, IN
The Effects of Obesity and Protein Intake on the Kidney
The Effects of Obesity and Protein Intake on the Kidney
Status: Enrolling
Updated: 8/26/2015
University Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Very Low Calorie Diet for Diabetic Kidney Disease
Status: Enrolling
Updated:  8/27/2015
University Hospital
mi
from
Indianapolis, IN
Very Low Calorie Diet for Diabetic Kidney Disease
Status: Enrolling
Updated: 8/27/2015
University Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Antibody Response to Human Papillomavirus Recombinant Vaccine (Gardasil®) in Girls and Young Women With Chronic Kidney Disease
Antibody Response to Human Papillomavirus Recombinant Vaccine (Gardasil®) in Girls and Young Women With Chronic Kidney Disease
Status: Enrolling
Updated:  8/31/2015
Emory Healthcare & Children's Healthcare of Atlanta Pediatric Nephrology Clinic
mi
from
Atlanta, GA
Antibody Response to Human Papillomavirus Recombinant Vaccine (Gardasil®) in Girls and Young Women With Chronic Kidney Disease
Antibody Response to Human Papillomavirus Recombinant Vaccine (Gardasil®) in Girls and Young Women With Chronic Kidney Disease
Status: Enrolling
Updated: 8/31/2015
Emory Healthcare & Children's Healthcare of Atlanta Pediatric Nephrology Clinic
mi
from
Atlanta, GA
Click here to add this to my saved trials
Antibody Response to Human Papillomavirus Recombinant Vaccine (Gardasil®) in Girls and Young Women With Chronic Kidney Disease
Antibody Response to Human Papillomavirus Recombinant Vaccine (Gardasil®) in Girls and Young Women With Chronic Kidney Disease
Status: Enrolling
Updated:  8/31/2015
Johns Hopkins University Harriet Lane Kidney Center, Rubenstein Child Health Bldg
mi
from
Baltimore, MD
Antibody Response to Human Papillomavirus Recombinant Vaccine (Gardasil®) in Girls and Young Women With Chronic Kidney Disease
Antibody Response to Human Papillomavirus Recombinant Vaccine (Gardasil®) in Girls and Young Women With Chronic Kidney Disease
Status: Enrolling
Updated: 8/31/2015
Johns Hopkins University Harriet Lane Kidney Center, Rubenstein Child Health Bldg
mi
from
Baltimore, MD
Click here to add this to my saved trials
Study of the Effect of Renal Impairment on the Pharmacokinetics of Isavuconazole.
A Phase 1 Open Label, 2 Part, Parallel Group Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics of Isavuconazole
Status: Enrolling
Updated:  8/31/2015
DaVita Research
mi
from
Denver, CO
Study of the Effect of Renal Impairment on the Pharmacokinetics of Isavuconazole.
A Phase 1 Open Label, 2 Part, Parallel Group Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics of Isavuconazole
Status: Enrolling
Updated: 8/31/2015
DaVita Research
mi
from
Denver, CO
Click here to add this to my saved trials
Study of the Effect of Renal Impairment on the Pharmacokinetics of Isavuconazole.
A Phase 1 Open Label, 2 Part, Parallel Group Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics of Isavuconazole
Status: Enrolling
Updated:  8/31/2015
Clinical Pharmacology of Miami
mi
from
Miami, FL
Study of the Effect of Renal Impairment on the Pharmacokinetics of Isavuconazole.
A Phase 1 Open Label, 2 Part, Parallel Group Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics of Isavuconazole
Status: Enrolling
Updated: 8/31/2015
Clinical Pharmacology of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Study of the Effect of Renal Impairment on the Pharmacokinetics of Isavuconazole.
A Phase 1 Open Label, 2 Part, Parallel Group Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics of Isavuconazole
Status: Enrolling
Updated:  8/31/2015
DaVita Clinical Research
mi
from
Minneapolis, MN
Study of the Effect of Renal Impairment on the Pharmacokinetics of Isavuconazole.
A Phase 1 Open Label, 2 Part, Parallel Group Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics of Isavuconazole
Status: Enrolling
Updated: 8/31/2015
DaVita Clinical Research
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A Phase 2a Study of Weekly Doses of GCS-100 in Patients With Chronic Kidney Disease
A Phase 2a, Placebo-Controlled, Randomized, Single-Blind Study of Weekly Doses of GCS-100 in Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  8/31/2015
Southwest Clinical Research Institute
mi
from
Tempe, AZ
A Phase 2a Study of Weekly Doses of GCS-100 in Patients With Chronic Kidney Disease
A Phase 2a, Placebo-Controlled, Randomized, Single-Blind Study of Weekly Doses of GCS-100 in Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 8/31/2015
Southwest Clinical Research Institute
mi
from
Tempe, AZ
Click here to add this to my saved trials
A Phase 2a Study of Weekly Doses of GCS-100 in Patients With Chronic Kidney Disease
A Phase 2a, Placebo-Controlled, Randomized, Single-Blind Study of Weekly Doses of GCS-100 in Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  8/31/2015
California Institute of Renal Research
mi
from
La Mesa, CA
A Phase 2a Study of Weekly Doses of GCS-100 in Patients With Chronic Kidney Disease
A Phase 2a, Placebo-Controlled, Randomized, Single-Blind Study of Weekly Doses of GCS-100 in Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 8/31/2015
California Institute of Renal Research
mi
from
La Mesa, CA
Click here to add this to my saved trials
A Phase 2a Study of Weekly Doses of GCS-100 in Patients With Chronic Kidney Disease
A Phase 2a, Placebo-Controlled, Randomized, Single-Blind Study of Weekly Doses of GCS-100 in Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  8/31/2015
Denver Nephrology
mi
from
Denver, CO
A Phase 2a Study of Weekly Doses of GCS-100 in Patients With Chronic Kidney Disease
A Phase 2a, Placebo-Controlled, Randomized, Single-Blind Study of Weekly Doses of GCS-100 in Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 8/31/2015
Denver Nephrology
mi
from
Denver, CO
Click here to add this to my saved trials
A Phase 2a Study of Weekly Doses of GCS-100 in Patients With Chronic Kidney Disease
A Phase 2a, Placebo-Controlled, Randomized, Single-Blind Study of Weekly Doses of GCS-100 in Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  8/31/2015
Clinical Advancement Center, PLLC
mi
from
San Antonio, TX
A Phase 2a Study of Weekly Doses of GCS-100 in Patients With Chronic Kidney Disease
A Phase 2a, Placebo-Controlled, Randomized, Single-Blind Study of Weekly Doses of GCS-100 in Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 8/31/2015
Clinical Advancement Center, PLLC
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Phase 2 Extension Study of Study GCS-100-CS-4002
A Phase 2 Extension Study of Study GCS-100-CS-4002
Status: Enrolling
Updated:  8/31/2015
Southwest Clinical Research Institute
mi
from
Tempe, AZ
A Phase 2 Extension Study of Study GCS-100-CS-4002
A Phase 2 Extension Study of Study GCS-100-CS-4002
Status: Enrolling
Updated: 8/31/2015
Southwest Clinical Research Institute
mi
from
Tempe, AZ
Click here to add this to my saved trials
A Phase 2 Extension Study of Study GCS-100-CS-4002
A Phase 2 Extension Study of Study GCS-100-CS-4002
Status: Enrolling
Updated:  8/31/2015
California Institute of Renal Research
mi
from
La Mesa, CA
A Phase 2 Extension Study of Study GCS-100-CS-4002
A Phase 2 Extension Study of Study GCS-100-CS-4002
Status: Enrolling
Updated: 8/31/2015
California Institute of Renal Research
mi
from
La Mesa, CA
Click here to add this to my saved trials
A Phase 2 Extension Study of Study GCS-100-CS-4002
A Phase 2 Extension Study of Study GCS-100-CS-4002
Status: Enrolling
Updated:  8/31/2015
Denver Nephrology
mi
from
Denver, CO
A Phase 2 Extension Study of Study GCS-100-CS-4002
A Phase 2 Extension Study of Study GCS-100-CS-4002
Status: Enrolling
Updated: 8/31/2015
Denver Nephrology
mi
from
Denver, CO
Click here to add this to my saved trials
A Phase 2 Extension Study of Study GCS-100-CS-4002
A Phase 2 Extension Study of Study GCS-100-CS-4002
Status: Enrolling
Updated:  8/31/2015
Mountain Kidney and Hypertension Associates
mi
from
Asheville, NC
A Phase 2 Extension Study of Study GCS-100-CS-4002
A Phase 2 Extension Study of Study GCS-100-CS-4002
Status: Enrolling
Updated: 8/31/2015
Mountain Kidney and Hypertension Associates
mi
from
Asheville, NC
Click here to add this to my saved trials
A Phase 2 Extension Study of Study GCS-100-CS-4002
A Phase 2 Extension Study of Study GCS-100-CS-4002
Status: Enrolling
Updated:  8/31/2015
Clinical Advancement Center, PLLC
mi
from
San Antonio, TX
A Phase 2 Extension Study of Study GCS-100-CS-4002
A Phase 2 Extension Study of Study GCS-100-CS-4002
Status: Enrolling
Updated: 8/31/2015
Clinical Advancement Center, PLLC
mi
from
San Antonio, TX
Click here to add this to my saved trials
Mapping Multidimensional Illness Trajectories of Patients With End-stage Kidney Disease
Mapping Multidimensional Illness Trajectories of Patients With ESKD
Status: Enrolling
Updated:  9/2/2015
UNC Hospitals and outpatient dialysis clinics
mi
from
Chapel Hill, NC
Mapping Multidimensional Illness Trajectories of Patients With End-stage Kidney Disease
Mapping Multidimensional Illness Trajectories of Patients With ESKD
Status: Enrolling
Updated: 9/2/2015
UNC Hospitals and outpatient dialysis clinics
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Study the Characteristics of Cardiac Related Events in Hemodialysis Patients
Monitoring in Dialysis
Status: Enrolling
Updated:  9/9/2015
Clinical Research Facility
mi
from
Augusta, GA
Study the Characteristics of Cardiac Related Events in Hemodialysis Patients
Monitoring in Dialysis
Status: Enrolling
Updated: 9/9/2015
Clinical Research Facility
mi
from
Augusta, GA
Click here to add this to my saved trials
Study the Characteristics of Cardiac Related Events in Hemodialysis Patients
Monitoring in Dialysis
Status: Enrolling
Updated:  9/9/2015
Clinical Research Facility
mi
from
Boston, MA
Study the Characteristics of Cardiac Related Events in Hemodialysis Patients
Monitoring in Dialysis
Status: Enrolling
Updated: 9/9/2015
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Study the Characteristics of Cardiac Related Events in Hemodialysis Patients
Monitoring in Dialysis
Status: Enrolling
Updated:  9/9/2015
Clinical Research Facility
mi
from
Cincinnati, OH
Study the Characteristics of Cardiac Related Events in Hemodialysis Patients
Monitoring in Dialysis
Status: Enrolling
Updated: 9/9/2015
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Study the Characteristics of Cardiac Related Events in Hemodialysis Patients
Monitoring in Dialysis
Status: Enrolling
Updated:  9/9/2015
Clinical Research Facility
mi
from
Chattanooga, TN
Study the Characteristics of Cardiac Related Events in Hemodialysis Patients
Monitoring in Dialysis
Status: Enrolling
Updated: 9/9/2015
Clinical Research Facility
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Study the Characteristics of Cardiac Related Events in Hemodialysis Patients
Monitoring in Dialysis
Status: Enrolling
Updated:  9/9/2015
Clinical Research Facility
mi
from
Houston, TX
Study the Characteristics of Cardiac Related Events in Hemodialysis Patients
Monitoring in Dialysis
Status: Enrolling
Updated: 9/9/2015
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Study the Characteristics of Cardiac Related Events in Hemodialysis Patients
Monitoring in Dialysis
Status: Enrolling
Updated:  9/9/2015
mi
from
Chennai,
Study the Characteristics of Cardiac Related Events in Hemodialysis Patients
Monitoring in Dialysis
Status: Enrolling
Updated: 9/9/2015
mi
from
Chennai,
Click here to add this to my saved trials
Immune Monitoring and CNI Withdrawal in Low Risk Recipients of Kidney Transplantation
Immune Monitoring and Calcineurin Inhibitor (CNI) Withdrawal in Low Risk Recipients of Kidney Transplantation
Status: Enrolling
Updated:  9/11/2015
University of California at Los Angeles
mi
from
Los Angeles, CA
Immune Monitoring and CNI Withdrawal in Low Risk Recipients of Kidney Transplantation
Immune Monitoring and Calcineurin Inhibitor (CNI) Withdrawal in Low Risk Recipients of Kidney Transplantation
Status: Enrolling
Updated: 9/11/2015
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Immune Monitoring and CNI Withdrawal in Low Risk Recipients of Kidney Transplantation
Immune Monitoring and Calcineurin Inhibitor (CNI) Withdrawal in Low Risk Recipients of Kidney Transplantation
Status: Enrolling
Updated:  9/11/2015
Yale University School of Medicine
mi
from
New Haven, CT
Immune Monitoring and CNI Withdrawal in Low Risk Recipients of Kidney Transplantation
Immune Monitoring and Calcineurin Inhibitor (CNI) Withdrawal in Low Risk Recipients of Kidney Transplantation
Status: Enrolling
Updated: 9/11/2015
Yale University School of Medicine
mi
from
New Haven, CT
Click here to add this to my saved trials
Immune Monitoring and CNI Withdrawal in Low Risk Recipients of Kidney Transplantation
Immune Monitoring and Calcineurin Inhibitor (CNI) Withdrawal in Low Risk Recipients of Kidney Transplantation
Status: Enrolling
Updated:  9/11/2015
Brigham and Women's Hosp
mi
from
Boston, MA
Immune Monitoring and CNI Withdrawal in Low Risk Recipients of Kidney Transplantation
Immune Monitoring and Calcineurin Inhibitor (CNI) Withdrawal in Low Risk Recipients of Kidney Transplantation
Status: Enrolling
Updated: 9/11/2015
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Immune Monitoring and CNI Withdrawal in Low Risk Recipients of Kidney Transplantation
Immune Monitoring and Calcineurin Inhibitor (CNI) Withdrawal in Low Risk Recipients of Kidney Transplantation
Status: Enrolling
Updated:  9/11/2015
Washington University
mi
from
St. Louis, MO
Immune Monitoring and CNI Withdrawal in Low Risk Recipients of Kidney Transplantation
Immune Monitoring and Calcineurin Inhibitor (CNI) Withdrawal in Low Risk Recipients of Kidney Transplantation
Status: Enrolling
Updated: 9/11/2015
Washington University
mi
from
St. Louis, MO
Click here to add this to my saved trials
Immune Monitoring and CNI Withdrawal in Low Risk Recipients of Kidney Transplantation
Immune Monitoring and Calcineurin Inhibitor (CNI) Withdrawal in Low Risk Recipients of Kidney Transplantation
Status: Enrolling
Updated:  9/11/2015
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Immune Monitoring and CNI Withdrawal in Low Risk Recipients of Kidney Transplantation
Immune Monitoring and Calcineurin Inhibitor (CNI) Withdrawal in Low Risk Recipients of Kidney Transplantation
Status: Enrolling
Updated: 9/11/2015
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Immune Monitoring and CNI Withdrawal in Low Risk Recipients of Kidney Transplantation
Immune Monitoring and Calcineurin Inhibitor (CNI) Withdrawal in Low Risk Recipients of Kidney Transplantation
Status: Enrolling
Updated:  9/11/2015
University Hospitals of Cleveland
mi
from
Cleveland, OH
Immune Monitoring and CNI Withdrawal in Low Risk Recipients of Kidney Transplantation
Immune Monitoring and Calcineurin Inhibitor (CNI) Withdrawal in Low Risk Recipients of Kidney Transplantation
Status: Enrolling
Updated: 9/11/2015
University Hospitals of Cleveland
mi
from
Cleveland, OH
Click here to add this to my saved trials
Immune Monitoring and CNI Withdrawal in Low Risk Recipients of Kidney Transplantation
Immune Monitoring and Calcineurin Inhibitor (CNI) Withdrawal in Low Risk Recipients of Kidney Transplantation
Status: Enrolling
Updated:  9/11/2015
University of Michigan Hospital
mi
from
Ann Arbor, MI
Immune Monitoring and CNI Withdrawal in Low Risk Recipients of Kidney Transplantation
Immune Monitoring and Calcineurin Inhibitor (CNI) Withdrawal in Low Risk Recipients of Kidney Transplantation
Status: Enrolling
Updated: 9/11/2015
University of Michigan Hospital
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Immune Monitoring and CNI Withdrawal in Low Risk Recipients of Kidney Transplantation
Immune Monitoring and Calcineurin Inhibitor (CNI) Withdrawal in Low Risk Recipients of Kidney Transplantation
Status: Enrolling
Updated:  9/11/2015
Mount Sinai School of Medicine
mi
from
New York, NY
Immune Monitoring and CNI Withdrawal in Low Risk Recipients of Kidney Transplantation
Immune Monitoring and Calcineurin Inhibitor (CNI) Withdrawal in Low Risk Recipients of Kidney Transplantation
Status: Enrolling
Updated: 9/11/2015
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Immune Monitoring and CNI Withdrawal in Low Risk Recipients of Kidney Transplantation
Immune Monitoring and Calcineurin Inhibitor (CNI) Withdrawal in Low Risk Recipients of Kidney Transplantation
Status: Enrolling
Updated:  9/11/2015
Methodist Hospital
mi
from
Houston, TX
Immune Monitoring and CNI Withdrawal in Low Risk Recipients of Kidney Transplantation
Immune Monitoring and Calcineurin Inhibitor (CNI) Withdrawal in Low Risk Recipients of Kidney Transplantation
Status: Enrolling
Updated: 9/11/2015
Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Immune Monitoring and CNI Withdrawal in Low Risk Recipients of Kidney Transplantation
Immune Monitoring and Calcineurin Inhibitor (CNI) Withdrawal in Low Risk Recipients of Kidney Transplantation
Status: Enrolling
Updated:  9/11/2015
Health Sciences Centre
mi
from
Winnipeg,
Immune Monitoring and CNI Withdrawal in Low Risk Recipients of Kidney Transplantation
Immune Monitoring and Calcineurin Inhibitor (CNI) Withdrawal in Low Risk Recipients of Kidney Transplantation
Status: Enrolling
Updated: 9/11/2015
Health Sciences Centre
mi
from
Winnipeg,
Click here to add this to my saved trials
Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO)
Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO)
Status: Enrolling
Updated:  9/15/2015
Clinical Investigative Site 1049
mi
from
San Diego, CA
Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO)
Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO)
Status: Enrolling
Updated: 9/15/2015
Clinical Investigative Site 1049
mi
from
San Diego, CA
Click here to add this to my saved trials
Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO)
Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO)
Status: Enrolling
Updated:  9/15/2015
Clinical Investigative Site 007
mi
from
Aurora, CO
Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO)
Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO)
Status: Enrolling
Updated: 9/15/2015
Clinical Investigative Site 007
mi
from
Aurora, CO
Click here to add this to my saved trials
Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO)
Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO)
Status: Enrolling
Updated:  9/15/2015
Clinical Investigative Site 005
mi
from
New Haven, CT
Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO)
Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO)
Status: Enrolling
Updated: 9/15/2015
Clinical Investigative Site 005
mi
from
New Haven, CT
Click here to add this to my saved trials
Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO)
Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO)
Status: Enrolling
Updated:  9/15/2015
Clinical Investigative Site 004
mi
from
Lexington, KY
Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO)
Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO)
Status: Enrolling
Updated: 9/15/2015
Clinical Investigative Site 004
mi
from
Lexington, KY
Click here to add this to my saved trials
Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO)
Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO)
Status: Enrolling
Updated:  9/15/2015
Clinical Investigative Site 008
mi
from
Minneapolis, MN
Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO)
Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO)
Status: Enrolling
Updated: 9/15/2015
Clinical Investigative Site 008
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO)
Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO)
Status: Enrolling
Updated:  9/15/2015
Clinical Investigative Site 003
mi
from
St Louis, MO
Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO)
Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO)
Status: Enrolling
Updated: 9/15/2015
Clinical Investigative Site 003
mi
from
St Louis, MO
Click here to add this to my saved trials
Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO)
Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO)
Status: Enrolling
Updated:  9/15/2015
Clinical Investigative Site 002
mi
from
Oklahoma City, OK
Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO)
Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO)
Status: Enrolling
Updated: 9/15/2015
Clinical Investigative Site 002
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO)
Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO)
Status: Enrolling
Updated:  9/15/2015
Clinical Investigative Site 009
mi
from
Nashiville, TN
Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO)
Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO)
Status: Enrolling
Updated: 9/15/2015
Clinical Investigative Site 009
mi
from
Nashiville, TN
Click here to add this to my saved trials
Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO)
Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO)
Status: Enrolling
Updated:  9/15/2015
Clinical Investigative Site # 6204
mi
from
Los Angeles, CA
Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO)
Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO)
Status: Enrolling
Updated: 9/15/2015
Clinical Investigative Site # 6204
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO)
Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO)
Status: Enrolling
Updated:  9/15/2015
Clinical Investigative Site 000013
mi
from
Dallas, TX
Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO)
Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO)
Status: Enrolling
Updated: 9/15/2015
Clinical Investigative Site 000013
mi
from
Dallas, TX
Click here to add this to my saved trials
A Trial Comparing Prograf and Neoral Use in Kidney Transplant Recipients of Hispanic Ethnicity
A Prospective, Open-label, Randomized Trial Comparing Prograf and Neoral Use in Kidney Transplant Recipients of Hispanic Ethnicity
Status: Enrolling
Updated:  9/17/2015
Loma Linda University Medical Center
mi
from
Loma Linda, CA
A Trial Comparing Prograf and Neoral Use in Kidney Transplant Recipients of Hispanic Ethnicity
A Prospective, Open-label, Randomized Trial Comparing Prograf and Neoral Use in Kidney Transplant Recipients of Hispanic Ethnicity
Status: Enrolling
Updated: 9/17/2015
Loma Linda University Medical Center
mi
from
Loma Linda, CA
Click here to add this to my saved trials
Journeys to Wellness: A Transplant Candidate Study
Mindfulness for Symptom Reduction: A Transplant Candidate Study in Program Grant Studies of Organ Transplantation in Animals and Man 2P01 DK013083
Status: Enrolling
Updated:  9/17/2015
Univ of Minnesota
mi
from
Minneapolis, MN
Journeys to Wellness: A Transplant Candidate Study
Mindfulness for Symptom Reduction: A Transplant Candidate Study in Program Grant Studies of Organ Transplantation in Animals and Man 2P01 DK013083
Status: Enrolling
Updated: 9/17/2015
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A Study in CKD Patients With Type 2 Diabetes Mellitus and Albuminuria
An Exploratory Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Design Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of AZD1722 in CKD Patients With Type 2 Diabetes Mellitus and Albuminuria
Status: Enrolling
Updated:  9/18/2015
Creekside Endocrine Associates PC
mi
from
Denver, CO
A Study in CKD Patients With Type 2 Diabetes Mellitus and Albuminuria
An Exploratory Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Design Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of AZD1722 in CKD Patients With Type 2 Diabetes Mellitus and Albuminuria
Status: Enrolling
Updated: 9/18/2015
Creekside Endocrine Associates PC
mi
from
Denver, CO
Click here to add this to my saved trials
Dose Finding Study to Treat High Phosphate Levels in the Blood.
A Phase 2b, Randomized, Double Blind, Placebo-controlled, Parallel Group, Multicentre Dose Finding Study to Evaluate the Efficacy, Safety and Tolerability of AZD1722 to Treat Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)
Status: Enrolling
Updated:  9/18/2015
Clinical Research Facility
mi
from
Downey, CA
Dose Finding Study to Treat High Phosphate Levels in the Blood.
A Phase 2b, Randomized, Double Blind, Placebo-controlled, Parallel Group, Multicentre Dose Finding Study to Evaluate the Efficacy, Safety and Tolerability of AZD1722 to Treat Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)
Status: Enrolling
Updated: 9/18/2015
Clinical Research Facility
mi
from
Downey, CA
Click here to add this to my saved trials
Dose Finding Study to Treat High Phosphate Levels in the Blood.
A Phase 2b, Randomized, Double Blind, Placebo-controlled, Parallel Group, Multicentre Dose Finding Study to Evaluate the Efficacy, Safety and Tolerability of AZD1722 to Treat Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)
Status: Enrolling
Updated:  9/18/2015
Clinical Research Facility
mi
from
Los Angeles, CA
Dose Finding Study to Treat High Phosphate Levels in the Blood.
A Phase 2b, Randomized, Double Blind, Placebo-controlled, Parallel Group, Multicentre Dose Finding Study to Evaluate the Efficacy, Safety and Tolerability of AZD1722 to Treat Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)
Status: Enrolling
Updated: 9/18/2015
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Dose Finding Study to Treat High Phosphate Levels in the Blood.
A Phase 2b, Randomized, Double Blind, Placebo-controlled, Parallel Group, Multicentre Dose Finding Study to Evaluate the Efficacy, Safety and Tolerability of AZD1722 to Treat Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)
Status: Enrolling
Updated:  9/18/2015
Clinical Research Facility
mi
from
Sacramento, CA
Dose Finding Study to Treat High Phosphate Levels in the Blood.
A Phase 2b, Randomized, Double Blind, Placebo-controlled, Parallel Group, Multicentre Dose Finding Study to Evaluate the Efficacy, Safety and Tolerability of AZD1722 to Treat Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)
Status: Enrolling
Updated: 9/18/2015
Clinical Research Facility
mi
from
Sacramento, CA
Click here to add this to my saved trials